Cellepathic

CellepathicRx inks key deal with medication adherence firm

Health IT startup CellepathicRx will provide the mobile platform for Adheris’ patient medication adherence program. The deal is worth noting because it’s significant for a young company like Cleveland-based CellepathicRx to receive validation of its technology from a more established company like Adheris, which works with pharmacies to help patients better follow medication instructions. Massachusetts-based […]

By Brandon Glenn

Health IT

Mobile patient medication adherence is aim of Cleveland startup

Health information technology company Access Mobility has developed a mobile patient medication adherence platform it calls CellepathicRx. A recent report found that patients' failure to follow physicians' instructions costs the U.S. health system nearly $300 billion per year.

By Brandon Glenn

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.

A Personalized Approach to Medication Nonadherence

At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.

CellepathicRx inks key deal with medication adherence firm

Mobile patient medication adherence is aim of Cleveland startup

When Investment Rhymes with Canada